NOVARTIS AG 15-29NOVARTIS AG 15-29NOVARTIS AG 15-29

NOVARTIS AG 15-29

No trades
See on Supercharts

Key terms


Outstanding amount
‪550.00 M‬CHF
Face value
5,000.00CHF
Minimum denomination
5,000.00CHF
Coupon
0.63% (Fixed)
Coupon frequency
Annual
Yield to maturity
0.71%
Maturity date
Nov 13, 2029
Term to maturity
4 years

About NOVARTIS AG 15-29


Sector
Health Technology
Home page
Issue date
Feb 13, 2015
ISIN
CH0270190991
FIGI
BBG0081YRF12
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.